Cardlytics Inc (CDLX)

Date: O: H: L: C: Vol:

Finanzdaten der Cardlytics Inc-Aktie (CDLX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	7.47%36.88	34.32	56.10	52.03	63.25
	13.84%5.54	6.43	-	-	-
Research and Development	13.84%5.54	6.43	-	-	-
Costs And Expenses	0.63%42.32	42.59	62.19	120.89	76.04
Depreciation and Amortization	2.99%4.06	3.94	6.21	6.47	6.28
Operating Income/Loss	34.24%-5.44	-8.27	-6.10	-68.85	-12.79
Nonoperating Income/Loss	41.75%-3.22	-5.52	-2.16	-3.82	3.51
Income/Loss From Continuing Operations Before Tax	37.24%-8.66	-13.80	-8.25	-72.67	-9.28
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	37.24%-8.66	-13.80	-8.25	-72.67	-9.28
Income/Loss From Discontinued Operations, Net Of Tax	166.72%-6.22	9.32	-	-	-
	232.05%-14.88	-4.48	-8.25	-72.67	-9.28
Attributable To Parent	232.05%-14.88	-4.48	-8.25	-72.67	-9.28
Basic Average Shares	89.51%5.76	54.90	0.41	53.49	52.75
Diluted Average Shares	89.51%5.76	54.90	0.41	53.49	52.75